Healthcare provider profile · identity verified

James Nesheiwat, MD

Internal Medicine · BRONX, NY · NPI 1487631792

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	362	41
Gabapentin	Gabapentin	331	54
Atorvastatin Calcium	Atorvastatin Calcium	329	73
Levothyroxine Sodium	Levothyroxine Sodium	276	31
Amlodipine Besylate	Amlodipine Besylate	224	40
Mirtazapine	Mirtazapine	166	32
Furosemide	Furosemide	161	28
Metoprolol Tartrate	Metoprolol Tartrate	152	22
Tamsulosin Hcl	Tamsulosin Hcl	152	25
Metformin Hcl	Metformin Hcl	148	24
Lisinopril	Lisinopril	140	17
Metoprolol Succinate	Metoprolol Succinate	140	25
Potassium Chloride	Potassium Chloride	138	28
Sertraline Hcl	Sertraline Hcl	127	22
Divalproex Sodium	Divalproex Sodium	105	15
Duloxetine Hcl	Duloxetine Hcl	105	19
Prednisone	Prednisone	96	23
Clopidogrel	Clopidogrel Bisulfate	94	16
Warfarin Sodium	Warfarin Sodium	91	suppressed
Levetiracetam	Levetiracetam	90	14
Quetiapine Fumarate	Quetiapine Fumarate	90	18
Oxycodone Hcl	Oxycodone Hcl	83	26
Risperidone	Risperidone	82	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	79	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	suppressed
Torsemide	Torsemide	71	13
Diltiazem 24hr Er (La)	Diltiazem Hcl	70	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	69	21
Humalog Kwikpen U-100	Insulin Lispro	67	suppressed
Latanoprost	Latanoprost	65	13
Famotidine	Famotidine	64	15
Citalopram Hbr	Citalopram Hydrobromide	63	suppressed
Lorazepam	Lorazepam	63	17
Trazodone Hcl	Trazodone Hcl	61	12
Losartan Potassium	Losartan Potassium	60	19
Carvedilol	Carvedilol	57	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	56	14
Alprazolam	Alprazolam	51	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	48	18
Januvia	Sitagliptin Phosphate	47	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	46	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	45	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	43	suppressed
Clonazepam	Clonazepam	42	suppressed
Tramadol Hcl	Tramadol Hcl	42	17
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	40	40
Allopurinol	Allopurinol	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	39	12
Digoxin	Digoxin	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	13
Finasteride	Finasteride	36	suppressed
Simvastatin	Simvastatin	36	suppressed
Cephalexin	Cephalexin	33	27
Scopolamine	Scopolamine	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Timolol Maleate	Timolol Maleate	28	suppressed
Brilinta	Ticagrelor	27	suppressed
Enulose	Lactulose	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	22
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Lactulose	Lactulose	26	12
Levofloxacin	Levofloxacin	26	18
Spironolactone	Spironolactone	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Carbamazepine Er	Carbamazepine	25	suppressed
Omeprazole	Omeprazole	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	13
Pilocarpine Hcl	Pilocarpine Hcl	20	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Valproic Acid	Valproic Acid	20	suppressed
Vascepa	Icosapent Ethyl	20	suppressed
Baclofen	Baclofen	19	suppressed
Benztropine Mesylate	Benztropine Mesylate	19	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Sodium Chloride	0.9 % Sodium Chloride	19	14
Amantadine	Amantadine Hcl	18	suppressed
Clozapine	Clozapine	18	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Oxcarbazepine	Oxcarbazepine	18	suppressed
Glipizide	Glipizide	17	suppressed
Mesalamine Er	Mesalamine	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Nystatin	Nystatin	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Nifedipine Er	Nifedipine	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Atenolol	Atenolol	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Betaxolol Hcl	Betaxolol Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Primidone	Primidone	12	suppressed
Acetazolamide Er	Acetazolamide	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Clomipramine Hcl	Clomipramine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Insulin Aspart	Insulin Aspart	11	suppressed
Levemir	Insulin Detemir	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error